Soleno Therapeutics, Inc. · NASDAQ:SLNO
Nantahala Capital Management, LLC reported a 9.99% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Nantahala Capital Management, LLC reported a 9.99% stake in Soleno Therapeutics, Inc., 4,349,435 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 4,349,435
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 4,349,435 |
| Wilmot B. Harkey | 9.99% | 4,349,435 |
| Daniel Mack | 9.99% | 4,349,435 |
Source
Related
- Soleno Therapeutics, Inc.
- Nantahala Capital Management, LLC
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2025
- Schedule 13G/A · Nantahala Capital Management, LLC · Apr 30, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026